Skyline Medical Receives Health Canada Approval To Market STREAMWAY® System

MINNEAPOLIS, Nov. 22, 2016 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces that it has received a Medical Device Establishment License to sell the STREAMWAY System and related disposables in Canada.

A number of distributors have expressed interest in selling STREAMWAY into Canada's healthcare system.  Skyline has now begun talks with several of them and expects within the next few weeks to come to terms with one or more distributors, covering approximately 1,500 hospitals in all 13 provinces of Canada.

"We look forward to bringing the STREAMWAY System and its many benefits to healthcare professionals and facilities to the approximately 10,000 operating rooms across Canada," said Dr. Carl Schwartz, executive chairman of Skyline Medical. "This approval follows receipt of ISO 13485:2003 certification for the STREAMWAY System, which not only was a requirement for Canadian approval, but is necessary for the CE Mark and subsequent sales in the European Union. We are pleased to reach this important milestone in our plans for broader distribution of the STREAMWAY System."

About the STREAMWAY System

Skyline's revolutionary, FDA-cleared STREAMWAY system is the first true direct-to-drain fluid disposal system designed specifically for medical applications, such as radiology, endoscopy, urology and cystoscopy procedures. It connects directly to a facility's plumbing system to automate the collection, measurement and disposal of waste fluids.  As of September 30, 2016, Skyline Medical customers have installed 96 STREAMWAY systems in 50 facilities across 19 states.

If you liked this article you might like

These 3 Big 2016 Losers Look Like They Will Continue to Struggle

Rotation Is the Name of the Game

Skyline Medical Shares Soar After Announcing UK Distribution Deal

Trending Tickers: AA, BKD, SKLN, CMI